14-34710631-GA-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_138638.5(CFL2):c.*2233del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 436,424 control chromosomes in the GnomAD database, including 6 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0035 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 1 hom. )
Consequence
CFL2
NM_138638.5 3_prime_UTR
NM_138638.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.42
Genes affected
CFL2 (HGNC:1875): (cofilin 2) This gene encodes an intracellular protein that is involved in the regulation of actin-filament dynamics. This protein is a major component of intranuclear and cytoplasmic actin rods. It can bind G- and F-actin in a 1:1 ratio of cofilin to actin, and it reversibly controls actin polymerization and depolymerization in a pH-dependent manner. Mutations in this gene cause nemaline myopathy type 7, a form of congenital myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00354 (538/152182) while in subpopulation AFR AF= 0.0125 (520/41510). AF 95% confidence interval is 0.0116. There are 5 homozygotes in gnomad4. There are 254 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFL2 | NM_138638.5 | c.*2233del | 3_prime_UTR_variant | 4/4 | ENST00000298159.11 | NP_619579.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFL2 | ENST00000298159.11 | c.*2233del | 3_prime_UTR_variant | 4/4 | 1 | NM_138638.5 | ENSP00000298159 | P1 | ||
CFL2 | ENST00000341223.8 | c.*2233del | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000340635 | P1 | |||
CFL2 | ENST00000672517.1 | c.*2233del | 3_prime_UTR_variant | 5/5 | ENSP00000500532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00354 AC: 538AN: 152064Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
538
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000848 AC: 104AN: 122696Hom.: 1 AF XY: 0.000694 AC XY: 46AN XY: 66306
GnomAD3 exomes
AF:
AC:
104
AN:
122696
Hom.:
AF XY:
AC XY:
46
AN XY:
66306
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000471 AC: 134AN: 284242Hom.: 1 Cov.: 0 AF XY: 0.000347 AC XY: 56AN XY: 161606
GnomAD4 exome
AF:
AC:
134
AN:
284242
Hom.:
Cov.:
0
AF XY:
AC XY:
56
AN XY:
161606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00354 AC: 538AN: 152182Hom.: 5 Cov.: 32 AF XY: 0.00341 AC XY: 254AN XY: 74416
GnomAD4 genome
AF:
AC:
538
AN:
152182
Hom.:
Cov.:
32
AF XY:
AC XY:
254
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3452
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nemaline Myopathy, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at